Clinical Trials Logo

Clinical Trial Summary

This is an open label study with the aim to estimate the incidence of moderate and severe diarrhea among participants challenged with an enterotoxigenic E. coli (ETEC) strain. This strain is planned to be used in a subsequent challenge study on the efficacy of an oral inactivated ETEC vaccine. The study will be conducted at one site; the Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland, United States.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06290089
Study type Interventional
Source Scandinavian Biopharma AB
Contact
Status Recruiting
Phase N/A
Start date February 12, 2024
Completion date September 2024